{"id":481414,"date":"2026-07-18T07:01:38","date_gmt":"2026-07-17T21:01:38","guid":{"rendered":"https:\/\/www.nasa.gov\/?p=1018603"},"modified":"2026-07-18T07:01:38","modified_gmt":"2026-07-17T21:01:38","slug":"establishing-a-vte-risk-score-for-astronauts-algorithm","status":"publish","type":"post","link":"https:\/\/www.vibewire.com.au\/?p=481414","title":{"rendered":"Establishing a VTE Risk Score for Astronauts Algorithm"},"content":{"rendered":"
\n
\n
\n
\"\"<\/a><\/figure>
\n
Spontaneous echo contrast (SEC) grade 3 with peripheral echogenicity.<\/div>\n
NASA\/Pavela<\/div>\n<\/figcaption><\/div>\n<\/div>\n<\/div>\n
<\/div>\n
\n\t
\n\t\tNASA\/SP-20260005258\/REV1 – NASA Risk of Venous Thromboembolism in Spaceflight – Outcomes of Working Group Meeting \u2013 April 2026<\/span>
\n\t\t<\/circle><\/path><\/svg>
\n\t<\/a><\/p><\/div>\n
<\/div>\n

In April 2026, NASA\u2019s Office of the Chief Health and Medical Officer (OCHMO) initiated a working group to review updated VTE case information, additional data gathered revealing altered blood flow status within a cohort of astronauts, and discuss progress of research and clinical activities intended to mitigate the risk of VTE during spaceflight with new evidence-based clinical practice recommendations. <\/p>\n

<\/div>\n

Recommendations<\/h2>\n

The following is a summary of the working group\u2019s recommendations:<\/p>\n